These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33622500)

  • 1. Psychological Flexibility as Shared Process of Change in Acceptance and Commitment Therapy and Exposure and Response Prevention for Obsessive-Compulsive Disorder: A Single Case Design Study.
    Thompson BL; Twohig MP; Luoma JB
    Behav Ther; 2021 Mar; 52(2):286-297. PubMed ID: 33622500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding acceptance and commitment therapy to exposure and response prevention for obsessive-compulsive disorder: A randomized controlled trial.
    Twohig MP; Abramowitz JS; Smith BM; Fabricant LE; Jacoby RJ; Morrison KL; Bluett EJ; Reuman L; Blakey SM; Ledermann T
    Behav Res Ther; 2018 Sep; 108():1-9. PubMed ID: 29966992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating an Acceptance and Commitment Therapy-Based Exposure Therapy Intervention in Treatment-Refractory OCD and Related Disorders: Changes in Psychological Flexibility, Treatment Engagement, and Treatment Perceptions.
    Gruner NG; Cullen JM; Crosby JM; DeCross SN; Mathes B; Garner L; Gironda C; Hu Y; Krompinger JW; Elias JA; Twohig MP
    J Cogn Psychother; 2024 Jul; 38(3):255-272. PubMed ID: 38991743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Disorder on an Optimal Dose of SSRIs: A Randomized Controlled Trial in Iran.
    Zemestani M; Salavati M; Seyedolshohadayi A; Petersen JM; Ong CW; Twohig MP; Ghaderi E
    Behav Modif; 2022 May; 46(3):553-580. PubMed ID: 33356487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance and commitment therapy for a case of scrupulosity-related obsessive-compulsive disorder.
    Lee EB; Ong CW; An W; Twohig MP
    Bull Menninger Clin; 2018; 82(4):407-423. PubMed ID: 30589574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Psychological Processes in Traditional and ACT-Enhanced ERP for Obsessive-Compulsive Disorder.
    Buchholz JL; Abramowitz JS; Hellberg SN; Ojalehto HJ; Twohig M
    J Cogn Psychother; 2023 Jul; 37(3):239-251. PubMed ID: 37463698
    [No Abstract]   [Full Text] [Related]  

  • 7. Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting.
    Rector NA; Richter MA; Katz D; Leybman M
    Br J Clin Psychol; 2019 Mar; 58(1):1-18. PubMed ID: 29984550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mindfulness-based exposure and response prevention for obsessive compulsive disorder: study protocol for a pilot randomised controlled trial.
    Strauss C; Rosten C; Hayward M; Lea L; Forrester E; Jones AM
    Trials; 2015 Apr; 16():167. PubMed ID: 25886875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scoping Review of Acceptance and Commitment Therapy for Obsessive-Compulsive Disorder in Iran.
    Twohig MP; Seydavi M; Capel LK; Levin ME; Akbari M
    J Cogn Psychother; 2024 Jul; 38(3):211-226. PubMed ID: 38991742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to exposure and response prevention as a predictor of improvement in obsessive-compulsive symptom dimensions.
    Ojalehto HJ; Abramowitz JS; Hellberg SN; Buchholz JL; Twohig MP
    J Anxiety Disord; 2020 May; 72():102210. PubMed ID: 32208231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How willing are you? Willingness as a predictor of change during treatment of adults with obsessive-compulsive disorder.
    Reid AM; Garner LE; Van Kirk N; Gironda C; Krompinger JW; Brennan BP; Mathes BM; Monaghan SC; Tifft ED; André MC; Cattie J; Crosby JM; Elias JA
    Depress Anxiety; 2017 Nov; 34(11):1057-1064. PubMed ID: 28715850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mindfulness-based exposure and response prevention for obsessive compulsive disorder: Findings from a pilot randomised controlled trial.
    Strauss C; Lea L; Hayward M; Forrester E; Leeuwerik T; Jones AM; Rosten C
    J Anxiety Disord; 2018 Jun; 57():39-47. PubMed ID: 29739634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary evidence of the effectiveness of acceptance and commitment therapy for death anxiety in Iranian clients diagnosed with obsessive-compulsive disorder.
    Davazdahemami MH; Bayrami A; Petersen JM; Twohig MP; Bakhtiyari M; Noori M; Kheradmand A
    Bull Menninger Clin; 2020 Oct; 84(Supplement A):1-11. PubMed ID: 33074020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder: study protocol for a randomized controlled trial.
    Melchior K; Franken I; Deen M; van der Heiden C
    Trials; 2019 May; 20(1):277. PubMed ID: 31109349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Kvale G; Hansen B; Hagen K; Abramowitz JS; Børtveit T; Craske MG; Franklin ME; Haseth S; Himle JA; Hystad S; Kristensen UB; Launes G; Lund A; Solem S; Öst LG
    JAMA Netw Open; 2020 Aug; 3(8):e2013249. PubMed ID: 32789516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure and response prevention with or without parent management training for children with obsessive-compulsive disorder complicated by disruptive behavior: a multiple-baseline across-responses design study.
    Sukhodolsky DG; Gorman BS; Scahill L; Findley D; McGuire J
    J Anxiety Disord; 2013 Apr; 27(3):298-305. PubMed ID: 23602943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Exposure and Response Prevention Behaviorally Activate Patients With Obsessive-Compulsive Disorder? A Preliminary Test.
    Blakey SM; Abramowitz JS; Leonard RC; Riemann BC
    Behav Ther; 2019 Jan; 50(1):214-224. PubMed ID: 30661561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metacognitive therapy for obsessive-compulsive disorder: A case report.
    Melchior K; Franken IHA; van der Heiden C
    Bull Menninger Clin; 2018; 82(4):375-389. PubMed ID: 30589580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptance and commitment therapy for anxiety and OCD spectrum disorders: an empirical review.
    Bluett EJ; Homan KJ; Morrison KL; Levin ME; Twohig MP
    J Anxiety Disord; 2014 Aug; 28(6):612-24. PubMed ID: 25041735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.